Why did TLIK.F stock fall 31% today?

The 31.05% drop reflects thin liquidity and sudden selling pressure, not a scheduled earnings release. Low volume (500) and tiny market cap make TLIK.F stock prone to sharp moves when holders trade.

What are the fundamentals of Arzneiwerk AG VIDA (TLIK.F)?

Fundamentals show negative EPS **€-0.11**, PE **-2.38**, current ratio **0.04**, and negative operating cash flow per share **€-0.35**, indicating cash and solvency pressure for TLIK.F stock.

What price path does Meyka AI forecast for TLIK.F stock?

Meyka AI's forecast model projects a monthly price around **€0.27**, roughly **+3.05%** from **€0.262**. Forecasts are model projections and not guarantees for TLIK.F stock.

Should investors buy TLIK.F stock after the drop?

Given micro-cap risk, negative cash flow, and low liquidity, potential buyers should treat TLIK.F stock as speculative. Risk-tolerant traders may use tight position sizing and clear exit rules.

DE Stocks

TLIK.F down 31% intraday on XETRA 09 Feb 2026: watch liquidity and valuation

ByHuzaifa Zahoor February 9, 2026

The TLIK.F stock plunged 31.05% intraday on XETRA to €0.262 on 09 Feb 2026, making Arzneiwerk AG VIDA one of today’s top losers. The fall follows thin trading—volume 500 vs average 470—and highlights the firm’s low liquidity and weak balance-sheet metrics. Investors should note the negative earnings trend: EPS €-0.11 and PE -2.38. With the Healthcare sector up modestly today, TLIK.F’s move looks stock-specific and raises short-term downside risk while opening a scenario-based recovery path for traders watching valuation and float activity.